PL2968427T3 - Koniugat do indukowania przeciwciał ukierunkowanych na polisacharydy ściany komórkowej grzybów - Google Patents
Koniugat do indukowania przeciwciał ukierunkowanych na polisacharydy ściany komórkowej grzybówInfo
- Publication number
- PL2968427T3 PL2968427T3 PL14774732.3T PL14774732T PL2968427T3 PL 2968427 T3 PL2968427 T3 PL 2968427T3 PL 14774732 T PL14774732 T PL 14774732T PL 2968427 T3 PL2968427 T3 PL 2968427T3
- Authority
- PL
- Poland
- Prior art keywords
- conjugate
- cell wall
- fungal cell
- antibodies targeting
- inducing antibodies
- Prior art date
Links
- 210000002421 cell wall Anatomy 0.000 title 1
- 230000002538 fungal effect Effects 0.000 title 1
- 150000004676 glycans Chemical class 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 229920001282 polysaccharide Polymers 0.000 title 1
- 239000005017 polysaccharide Substances 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361777631P | 2013-03-12 | 2013-03-12 | |
| PCT/US2014/021128 WO2014158963A1 (en) | 2013-03-12 | 2014-03-06 | Antibodies targeted to fungal cell wall polysaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2968427T3 true PL2968427T3 (pl) | 2023-02-27 |
Family
ID=51625093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14774732.3T PL2968427T3 (pl) | 2013-03-12 | 2014-03-06 | Koniugat do indukowania przeciwciał ukierunkowanych na polisacharydy ściany komórkowej grzybów |
Country Status (10)
| Country | Link |
|---|---|
| US (6) | US20160017062A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2968427B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6434958B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105188725B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2014241492A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2968427T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2936811T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI2968427T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2968427T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014158963A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2968427T3 (da) * | 2013-03-12 | 2023-01-30 | Wellstat Vaccines Llc | Konjugat til induktion af antistoffer målrettet mod svampecellevægges polysaccharider |
| CN111707815A (zh) * | 2019-12-31 | 2020-09-25 | 安徽中医药大学 | 一种通过白色念珠菌细胞壁重构来评价中药单体抗真菌作用的方法 |
| CN111679069A (zh) * | 2019-12-31 | 2020-09-18 | 安徽中医药大学 | 一种通过耳道念珠菌细胞壁重构来评价中药单体抗真菌作用的方法 |
| CN113274489B (zh) * | 2021-04-30 | 2023-08-29 | 山东省药学科学院 | 一种预防真菌感染的几丁质寡糖疫苗及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62138496A (ja) | 1985-12-11 | 1987-06-22 | Ihara Chem Ind Co Ltd | キチンオリゴマ−の製造方法 |
| JP2871822B2 (ja) * | 1989-08-29 | 1999-03-17 | 玉造株式会社 | 末端に２，５―アンヒドロマンニトール基または２，５―アンヒドロマンノース基を有するキチン・キトサンオリゴマーおよびその製造方法 |
| JP2868635B2 (ja) * | 1991-02-25 | 1999-03-10 | 玉造株式会社 | キチン・キトサンオリゴマーの精製方法 |
| JP2786389B2 (ja) * | 1993-05-18 | 1998-08-13 | 玉造株式会社 | 腫瘍免疫治療剤 |
| US5705634A (en) | 1995-03-02 | 1998-01-06 | Perimmune Holdings, Inc. | High yield preparation of dimeric to decameric chitin oligomers |
| US6284884B1 (en) * | 1995-06-07 | 2001-09-04 | North American Vaccine, Inc. | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| US7153943B2 (en) * | 1997-07-14 | 2006-12-26 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins, and methods of use thereof |
| ES2357889T3 (es) * | 2001-11-15 | 2011-05-03 | Piramal Healthcare (Canada) Limited | Composición y método para reticular o modificar homogéneamente quitosano en condiciones neutras. |
| GB0211118D0 (en) | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
| WO2006096970A1 (en) * | 2005-03-14 | 2006-09-21 | Governors Of The University Of Alberta | Synthetic anti-candida albicans oligosaccharide based vaccines |
| MX336736B (es) | 2005-06-14 | 2016-01-29 | Genis Hf | Composiciones de derivados de quitina parcialmente desacetilados. |
| KR100793756B1 (ko) * | 2006-08-07 | 2008-01-10 | 엘지전자 주식회사 | 녹화 목록 표시 방법 및 그 장치 |
| US20080311595A1 (en) | 2007-06-18 | 2008-12-18 | Inger Mattsby-Baltzer | Rapid fungal detection assay and product |
| GB2460965B (en) * | 2008-03-13 | 2010-05-19 | Academia Sinica | Fibrillar albumin and uses thereof |
| EP2123261A1 (en) | 2008-05-20 | 2009-11-25 | Stallergenes S.A. | Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance |
| DK2315747T3 (en) | 2008-07-21 | 2018-02-26 | Brigham & Womens Hospital Inc | Methods and Compositions of Synthetic Beta-1.6 Glucosamine Oligosaccharides |
| WO2010015022A1 (en) * | 2008-08-05 | 2010-02-11 | The University Of Queensland | Antigen-presenting scaffolds |
| CN102170904A (zh) | 2008-09-05 | 2011-08-31 | 诗华动物保健股份有限公司 | 用于给禽类经眼施用疫苗的包含壳聚糖的组合物 |
| CN102197119B (zh) | 2008-10-23 | 2015-08-12 | 路博润公司 | 含金属羧酸盐的润滑组合物 |
| JP5617127B2 (ja) * | 2009-05-08 | 2014-11-05 | 大石 哲也 | 新規グアナミン化合物、その誘導体及びそれらの製造方法 |
| WO2011080595A2 (en) * | 2009-12-30 | 2011-07-07 | Novartis Ag | Polysaccharide immunogens conjugated to e. coli carrier proteins |
| JP2012241084A (ja) * | 2011-05-18 | 2012-12-10 | Nippon Terupen Kagaku Kk | バインダー樹脂用溶剤 |
| DK2968427T3 (da) * | 2013-03-12 | 2023-01-30 | Wellstat Vaccines Llc | Konjugat til induktion af antistoffer målrettet mod svampecellevægges polysaccharider |
-
2014
- 2014-03-06 DK DK14774732.3T patent/DK2968427T3/da active
- 2014-03-06 AU AU2014241492A patent/AU2014241492A1/en not_active Abandoned
- 2014-03-06 EP EP14774732.3A patent/EP2968427B1/en active Active
- 2014-03-06 FI FIEP14774732.3T patent/FI2968427T3/fi active
- 2014-03-06 JP JP2016500727A patent/JP6434958B2/ja not_active Expired - Fee Related
- 2014-03-06 CN CN201480026536.9A patent/CN105188725B/zh not_active Expired - Fee Related
- 2014-03-06 ES ES14774732T patent/ES2936811T3/es active Active
- 2014-03-06 PL PL14774732.3T patent/PL2968427T3/pl unknown
- 2014-03-06 WO PCT/US2014/021128 patent/WO2014158963A1/en not_active Ceased
- 2014-03-06 US US14/771,923 patent/US20160017062A1/en not_active Abandoned
-
2017
- 2017-05-01 US US15/583,396 patent/US10259888B2/en not_active Expired - Fee Related
-
2018
- 2018-07-19 JP JP2018135654A patent/JP2018172696A/ja active Pending
-
2019
- 2019-02-05 US US16/267,430 patent/US10519253B2/en active Active
- 2019-10-29 US US16/666,503 patent/US10752704B2/en active Active
-
2020
- 2020-07-14 US US16/928,545 patent/US10988552B2/en active Active
-
2021
- 2021-03-23 US US17/210,124 patent/US20210301037A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014158963A1 (en) | 2014-10-02 |
| CN105188725A (zh) | 2015-12-23 |
| US10259888B2 (en) | 2019-04-16 |
| EP2968427B1 (en) | 2022-10-26 |
| CN105188725B (zh) | 2020-08-21 |
| JP2016513747A (ja) | 2016-05-16 |
| JP6434958B2 (ja) | 2018-12-05 |
| DK2968427T3 (da) | 2023-01-30 |
| US20200339707A1 (en) | 2020-10-29 |
| US20160017062A1 (en) | 2016-01-21 |
| US20180251573A1 (en) | 2018-09-06 |
| US10519253B2 (en) | 2019-12-31 |
| EP2968427A4 (en) | 2016-08-31 |
| US10752704B2 (en) | 2020-08-25 |
| US20200062866A1 (en) | 2020-02-27 |
| EP2968427A1 (en) | 2016-01-20 |
| AU2014241492A1 (en) | 2015-09-17 |
| FI2968427T3 (fi) | 2023-03-01 |
| ES2936811T3 (es) | 2023-03-22 |
| US20210301037A1 (en) | 2021-09-30 |
| US20190169315A1 (en) | 2019-06-06 |
| JP2018172696A (ja) | 2018-11-08 |
| HK1220360A1 (en) | 2017-05-05 |
| US10988552B2 (en) | 2021-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL244816A0 (en) | Protein-polymer-drug conjugates | |
| IL245009A0 (en) | Attach a drug from a protein and a polymer | |
| IL241277A0 (en) | Antibody-drug conjugates | |
| ZA201502267B (en) | Pyrrolobenzodiazepine-anti-her2 antibody conjugates | |
| IL243129B (en) | Anti–fcrh5 antibodies | |
| PL2906253T3 (pl) | Koniugaty pirolobenzodiazepina-przeciwciało anty-psma | |
| LT2906251T (lt) | Pirolobenzodiazepino-anti-cd22 antikūno konjugatai | |
| SG11201605260VA (en) | Var2csa-drug conjugates | |
| GB201322583D0 (en) | Antibodies | |
| ZA201508487B (en) | Antibody drug conjugates | |
| GB201315487D0 (en) | Antibodies | |
| EP3059225A4 (en) | Novel alkylene derivative | |
| IL240920A0 (en) | Cyclosporine a-steroid conjugates | |
| GB201314655D0 (en) | Hydrophobic bank | |
| GB201308658D0 (en) | Antibodies | |
| GB201312226D0 (en) | Improved antibodies | |
| ZA201507251B (en) | Antibodies targeting m-csf | |
| PL2968427T3 (pl) | Koniugat do indukowania przeciwciał ukierunkowanych na polisacharydy ściany komórkowej grzybów | |
| GB201300232D0 (en) | Drivetrain connections | |
| GB201316666D0 (en) | Targeting molecule | |
| PL2978847T3 (pl) | Rybozymy typu hammerhead skierowane przeciw mir-21 | |
| PL2860314T3 (pl) | Fundamentowanie grawitacyjne | |
| HK1230630A1 (en) | Var2csa-drug conjugates | |
| GB201313754D0 (en) | Transaction pouch | |
| GB201318283D0 (en) | Antibodies |